ProLynx announces preclinical results of long-acting semaglutide requiring once monthly dosing
August 21, 2024 14:16 ET
|
ProLynx Inc.
SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- ProLynx Inc. today announced the use of their technology to create a long-acting semaglutide that can be administered once monthly. The ProLynx...
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 14, 2024 16:05 ET
|
Fractyl Health, Inc.
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024 09:05 ET
|
Elevai Labs Inc.
Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial results
August 12, 2024 11:00 ET
|
Zealand Pharma
Press Release – No. 8 / 2024 Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial results Copenhagen, Denmark, August 12,...
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure
August 08, 2024 08:00 ET
|
Fractyl Health, Inc.
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single
Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
August 07, 2024 07:00 ET
|
Fractyl Health, Inc.
Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
Obesity Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
August 06, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Obesity Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight Obesity...
Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug
August 06, 2024 08:57 ET
|
Clearmind Medicine Inc.
Vancouver, Canada, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
NodThera Named a ‘Fierce 15’ Company by Fierce Biotech
August 05, 2024 10:16 ET
|
NodThera
NodThera Named a ‘Fierce 15’ Company by Fierce Biotech Philadelphia, PA, August 5, 2024 - NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of chronic...
NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer
August 01, 2024 07:00 ET
|
NodThera
NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer Greg brings over 25 years of public and private company leadership experience Philadelphia, PA, August 1, 2024 -...